QuanBio: Predictive hemodynamic intelligence grounded in continuous vascular physiology

QuanBio is building the continuous cardiovascular intelligence infrastructure layer for high-acuity cardiovascular care, intervention-driven recovery, and longitudinal physiologic analysis.

The company develops continuous hemodynamic intelligence derived directly from human vascular physiology — focusing on how blood vessels behave, adapt, and fail across intervention, recovery, and disease progression. QuanBio generates continuous, intervention-linked physiologic insight often invisible to static diagnostics, episodic assessments, and retrospective datasets.

The platform computes proprietary AI-derived biomarkers associated with vascular stability, microvascular perfusion, renal stress, inflammatory instability, and recovery trajectory before conventional clinical deterioration becomes clinically apparent.

Operating across active cardiovascular and transplant environments, QuanBio continuously generates longitudinal physiologic intelligence spanning cardiovascular intervention, recovery monitoring, and outcome-linked real-world evidence generation.

QuanBio operates at the intersection of hemodynamics, vascular biology, longitudinal real-world evidence, and computational physiology — building a new foundation for cardiovascular recovery, intervention-linked therapeutics, and next-generation life-science infrastructure.

QuanBio.com

Org chart

Teams

Offices

QuanBio.com

Org chart

Teams

Offices

Related companies